Articles «Previous Next»

Why Are So Few Acute Stroke Patients Receiving Tissue Plasminogen Activator Therapy?

Derek Bambauer, Brooklyn Law School
K. Z. Bambauer
S. C. Johnston
J. A. Zivin

Suggested Citation

Derek Bambauer, K. Z. Bambauer, S. C. Johnston, and J. A. Zivin. "Why Are So Few Acute Stroke Patients Receiving Tissue Plasminogen Activator Therapy?" 63 Archives of Neurology 661 (2006) (co-authors: K.Z. Bambauer, S.C. Johnston, J.A. Zivin)

The full text of this version of the article is not currently available here. Bookmark